Spring Bank Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SBPH and buy or sell other stocks, ETFs, and their options commission-free!About SBPH
F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies.
CEONeil Brewis, PhD
CEONeil Brewis, PhD
Employees—
Employees—
HeadquartersCambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded2002
Founded2002
Employees—
Employees—
SBPH Key Statistics
Market cap156.51M
Market cap156.51M
Price-Earnings ratio-3.44
Price-Earnings ratio-3.44
Dividend yield—
Dividend yield—
Average volume1.24M
Average volume1.24M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.12
52 Week high$7.12
52 Week low$2.07
52 Week low$2.07
Stock Snapshot
With a market cap of 156.51M, Spring Bank Pharmaceuticals(SBPH) trades at $7.12. The stock has a price-to-earnings ratio of -3.44.
On 2025-12-11, Spring Bank Pharmaceuticals(SBPH) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Spring Bank Pharmaceuticals(SBPH) stock has reached 0, versus its average volume of 1.24M.
Over the past 52 weeks, Spring Bank Pharmaceuticals(SBPH) stock has traded between a high of $7.12 and a low of $2.07.
Over the past 52 weeks, Spring Bank Pharmaceuticals(SBPH) stock has traded between a high of $7.12 and a low of $2.07.
People also own
Based on the portfolios of people who own SBPH. This list is generated using Robinhood data, and it’s not a recommendation.